Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
ProQR Therapeutics N.V.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Mar 20, 2026 | BioCryst Pharmaceuticals Inc. | Option exercise | +49,933 | $6.30 | $314,578 |
| Mar 20, 2026 | BioCryst Pharmaceuticals Inc. | Open-market sale | −49,933 | $10.11 | $504,823 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Option exercise | +30,000 | $2.91 | $87,300 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Option exercise | +40,000 | $5.41 | $216,400 |
| Aug 13, 2025 | BioCryst Pharmaceuticals Inc. | Open-market sale | −70,000 | $8.51 | $595,700 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 14, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −6,698 | $6.11 | $40,925 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| May 31, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +870 | $6.46 | $5,620 |
| Feb 29, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +999 | $5.63 | $5,624 |
| Nov 30, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +956 | $5.88 | $5,621 |
| Aug 31, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +791 | $7.11 | $5,624 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
| May 31, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +680 | $8.27 | $5,624 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.